Here, we demonstrate a microfluidic device that can isolate circulating plasma cells (CPCs) in MM by capture using CD138, a plasma cell marker that is highly expressed on plasma cell membranes19. The gene discussed is SDC1; the disease is Miyoshi myopathy.